The rising use of inorganic methods such as facility expansion by the industry's top players is likely to fuel market growth during the forecast period. Acne drug pipeline expansion and rising frequency of acne-related diseases are projected to fuel market growth during the forecast period. High adverse effects associated with acne drugs and increased usage of alternative therapies are the primary factors impeding expansion in the global acne medication industry. The kind and strength of the therapy affect the negative effects of acne drugs.
According to Coherent Market Insights, Global Acne Medication Market is estimated to be valued at US$ 7,594.3 million in 2022 and is expected to exhibit a CAGR of 4.5% during the forecast period (2022-2030).
Market Leaders in the Acne Medication Industry:
1. Galderma Laboratories, L.P
Galderma is the world's largest independent dermatology company, present in approximately 100 countries. Founded in 1981, headquartered in Vaud, Switzerland. On March 25, 2022 Galderma announced the U.S. launch of TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3% at the American Academy of Dermatology (AAD) Annual Meeting, March 25-29, 2022, in Boston, Massachusetts. TWYNEO Cream is the first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 combination proven to rapidly treat moderate to severe facial acne. In March 2021, Fortress Biotech, Inc., a biopharmaceutical company, announced a partnership with Journey Medical Corporation, a commercial-stage pharmaceutical company, to launch an oral isotretinoin under the brand name Accutane (isotretinoin capsules USP) in the U.S. Accutane is an oral medication that is indicated for the treatment of severe recalcitrant nodular acne.
2. GlaxoSmithKline plc.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV. Founded in 2000, headquartered in England, U.K.
3. Arctic Therapeutics International
Arcturus Therapeutics Holdings Inc. operates as a late-stage clinical mRNA medicines and vaccines company. Its technologies are covered by its patent portfolio, including patents and patent applications issued in the U.S., Europe, Japan, China, and other countries. The company was founded in 2013 and is headquartered in San Diego, California.
4. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company was founded in 1983 and is based in Mumbai, India. In July 2022, Sun Pharmaceutical Industries, an India-based pharmaceutical company, announced partnership with Cassiopea SpA, a clinical stage specialty pharmaceutical company, regarding a medication to treat acne.
5. AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide since 2012. It is headquartered in North Chicago and operational in more than 70 countries. AbbVie and HotSpot Therapeutics, Inc., in December, 2022
Biopharmx, Inc.
6. Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts. In February 2020, Paratek Pharmaceuticals, a commercial-stage biopharmaceutical company, and Almirall, a Spain-based pharmaceutical company, entered into a licensed agreement for SEYSARA, an antibiotic tablet for the treatment of acne for the Greater China region, which includes the People’s Republic of China, Hong Kong, and Macau. Under the terms of the agreement, Almirall will be responsible for the development, registration, and commercialization of the product in China.
7. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. On April 2021, Teva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States
8. Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company was founded in 1886 and is based in New Brunswick, New Jersey. Johnson & Johnson Consumer Health showcased research that emphasizes developments in understanding and treating skin at the 2022 American Academy of Dermatology (AAD) meeting, held in Boston, the US, from March 25 to 29. A total of 11 posters ranging from the effects of oat against environmental and anti-inflammatory triggers to a vitamin C serum with clinical benefits across diverse skin types were presented at this year’s meeting.
9. F. Hoffmann-La Roche Ltd
Roche Holding AG engages in the pharmaceuticals and diagnostics. The company was founded in 1896 and is headquartered in Basel, Switzerland.
*Definition- The face, forehead, chest, shoulders, and upper back are the most prevalent locations of the body where acne occurs on the skin. A few of the variables are genetics, changing hormone levels, stress, excessive humidity, and the use of greasy or oily personal care products.
